相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
Ryuichi Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia
K. Chiotis et al.
MOLECULAR PSYCHIATRY (2018)
Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
Renaud La Joie et al.
NEUROLOGY (2018)
Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease
Antoine Leuzy et al.
ALZHEIMERS & DEMENTIA (2018)
Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
Courtney L. Sutphen et al.
ALZHEIMERS & DEMENTIA (2018)
Tauomics and Kinetics in Human Neurons and Biological Fluids
Henrik Zetterberg
NEURON (2018)
Tau Kinetics in Neurons and the Human Central Nervous System
Chihiro Sato et al.
NEURON (2018)
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade et al.
NEUROLOGY (2018)
Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
Laetitia Lemoine et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography
Laetitia Lemoine et al.
SCIENTIFIC REPORTS (2017)
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2017)
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
Antoine Leuzy et al.
BRAIN (2016)
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A. Gordon et al.
BRAIN (2016)
Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm
Konstantinos Chiotis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology
My Jonasson et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
Jasmeer P. Chhatwal et al.
NEUROLOGY (2016)
Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease
Laure Saint-Aubert et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease
Ryuichi Harada et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue
Laetitia Lemoine et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Zhentao Zhang et al.
NATURE MEDICINE (2014)
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2013)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies
Junchao Tong et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease
Jere E. Meredith et al.
PLOS ONE (2013)
Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay
Stefan Foerster et al.
BIOLOGICAL PSYCHIATRY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease
Toni T. Seppala et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
Hippocampal atrophy rates in Alzheimer disease Added value over whole brain volume measures
W. J. P. Henneman et al.
NEUROLOGY (2009)
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease
R. Ceravolo et al.
BRAIN RESEARCH BULLETIN (2008)
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease
C. Haense et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2007)
No association of CSF biomarkers with APOEε4, plaque and tangle burden in definite Alzheimer's disease
Sebastiaan Engelborghs et al.
BRAIN (2007)
Computational tools for probing interactions in multiple linear regression, multilevel modeling, and latent curve analysis
Kristopher J. Preacher et al.
JOURNAL OF EDUCATIONAL AND BEHAVIORAL STATISTICS (2006)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment
A Fellgiebel et al.
BIOLOGICAL PSYCHIATRY (2004)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
A Hammers et al.
HUMAN BRAIN MAPPING (2003)
分享论文
